CompuGroup, DE000A288904

CompuGroup stock trades steady as investors watch recent earnings and guidance

Published on 09/09/2026 at 11:01 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

CompuGroup stock recently closed around EUR 27 on Xetra as of September 8, 2026, after the company reported its latest financial results earlier in 2026. The figures and guidance from the most recent reporting period remain a key reference point for investors.

Modernes E-Health-Büro mit Ärzten und digitalen Patientenakten, Koblenz
CompuGroup Medical zeigt moderne E-Health-Büros mit digitalen Patientenakten und vernetzten Ärzten, ISIN DE000A288904, Illustration mit AI erstellt.

CompuGroup Medical SE & Co. KGaA stock (ISIN DE000A288904) most recently changed hands at about EUR 27 on Xetra around September 8, 2026, leaving the healthcare IT specialist broadly stable after its latest earnings and guidance earlier in 2026. As of September 8, 2026, the shares stood close to recent trading levels highlighted on German stock portals, giving investors a reference point for the current valuation.

Earnings and revenue remain the anchor

CompuGroup Medical SE & Co. KGaA reported its most recent financial figures for the first half of 2026 earlier this year, including revenue, earnings and margin data for its core software and services business. According to Yahoo Finance, the company continues to be valued in the mid billions of euros, reflecting expectations that revenue and earnings for the latest fiscal year and the current year will grow versus prior periods.

Per the investor-relations information from CompuGroup Medical, the most recent annual report and interim report for 2026 highlight continued demand for digital healthcare solutions and software for doctors, hospitals and pharmacies. In that context, management confirmed its outlook for the current fiscal year 2026, targeting higher revenue and earnings compared with the prior year, though exact figures and growth rates depend on segment performance.

Stock valuation and trading range

On German trading platforms the shares of CompuGroup Medical recently traded around EUR 27.50 as of July 31, 2026 for the Frankfurt listing referenced by Yahoo Finance, while a real-time view from another portal showed EUR 27.63 at 11:39:46 on September 8, 2026, implying a modest gain of 0.09 percent over the previous 24 hours based on that source.

The current price near EUR 27 on Xetra and other German venues stands above historical levels seen in 2025, when one portal recorded closing prices around EUR 23.40 on several trading days in September 2025. That shift from about EUR 23.40 in September 2025 to roughly EUR 27.50 in late July 2026 illustrates how the market has rewarded CompuGroup Medical with an increase of roughly EUR 4.10 per share, or around 17.5 percent over that period, as investors priced in earnings progress and strategic developments.

Investor focus on guidance and margins

For investors looking at CompuGroup stock as of September 9, 2026, the key questions center on whether the company can deliver on its 2026 guidance and maintain or improve margins in its healthcare software segments. According to the company's latest guidance summary for fiscal year 2026 on CompuGroup Medical, management aims for higher revenue and operating profit compared with the previous year, supported by recurring software revenues and international expansion.

Compared with many global healthcare and pharma companies highlighted in sector commentary, CompuGroup Medical operates with a business model focused on digitalization and software rather than physical products. One recent sector analysis of healthcare earnings pointed to moderate revenue growth but stronger profit recovery for the broader industry in the first half of 2026, noting that operating profit for the medical sector in the second quarter rose significantly versus the prior year. While this report did not single out CompuGroup Medical, it underscores how investors currently favor companies that can convert modest revenue increases into more substantial earnings growth.

CompuGroup stock price snapshot

As of September 8, 2026, CompuGroup stock was quoted around EUR 27 on its primary German exchange, with recent intraday data from one portal showing EUR 27.63 at 11:39:46 and a 24-hour change of plus 0.09 percent. Over the last year, the share price has moved up from historical levels around EUR 23.40 in September 2025, indicating that the stock remains supported by expectations of continued growth in digital healthcare solutions. For investors, the combination of stable trading around EUR 27 and management's guidance for higher revenue and earnings in 2026 makes the upcoming reporting dates and any analyst updates important triggers for reassessing the valuation.

CompuGroup Medical stock facts

  • Company: CompuGroup Medical SE & Co. KGaA
  • ISIN: DE000A288904
  • WKN: A28890
  • Ticker: COP
  • Trading venue: Xetra
  • Price (as of September 8, 2026, 11:39): 27.63 EUR
  • Market capitalization: mid billions EUR (as of September 8, 2026)
  • Sector / Industry: Health care technology, software
  • Index membership: TecDAX

More news and analyses on CompuGroup Medical stock

Disclaimer...

en | DE000A288904 | COMPUGROUP | boerse | 70074165 | bgmi